| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Structure, Tertiary | 34 | 2015 | 4056 | 1.730 |
Why?
|
| Models, Molecular | 44 | 2020 | 5616 | 1.550 |
Why?
|
| Crystallography, X-Ray | 35 | 2022 | 2044 | 1.350 |
Why?
|
| Ubiquitin-Protein Ligases | 15 | 2015 | 1852 | 1.090 |
Why?
|
| Ubiquitin | 9 | 2017 | 848 | 0.980 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 4 | 2015 | 293 | 0.940 |
Why?
|
| Catalytic Domain | 12 | 2020 | 733 | 0.840 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 4 | 2015 | 86 | 0.820 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 6 | 2013 | 197 | 0.780 |
Why?
|
| Endopeptidases | 4 | 2013 | 831 | 0.740 |
Why?
|
| Peptidylprolyl Isomerase | 2 | 2010 | 111 | 0.730 |
Why?
|
| Amino Acid Sequence | 33 | 2021 | 14353 | 0.690 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2013 | 1628 | 0.690 |
Why?
|
| Protein Structure, Secondary | 14 | 2013 | 1248 | 0.680 |
Why?
|
| Protein Binding | 30 | 2021 | 9694 | 0.670 |
Why?
|
| Ubiquitin-Activating Enzymes | 3 | 2014 | 72 | 0.620 |
Why?
|
| Adenosine Triphosphate | 5 | 2018 | 2216 | 0.610 |
Why?
|
| Binding Sites | 19 | 2020 | 6335 | 0.600 |
Why?
|
| Molecular Sequence Data | 30 | 2013 | 18883 | 0.590 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 4 | 2020 | 445 | 0.510 |
Why?
|
| Protein Conformation | 18 | 2020 | 4107 | 0.510 |
Why?
|
| Lysosome-Associated Membrane Glycoproteins | 1 | 2013 | 109 | 0.500 |
Why?
|
| Cyclophilins | 2 | 2010 | 53 | 0.500 |
Why?
|
| Nuclear Proteins | 10 | 2022 | 5992 | 0.490 |
Why?
|
| Small Molecule Libraries | 8 | 2021 | 732 | 0.480 |
Why?
|
| Enzyme Inhibitors | 9 | 2021 | 3955 | 0.470 |
Why?
|
| Sequence Homology, Amino Acid | 14 | 2012 | 2950 | 0.470 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 2012 | 9 | 0.470 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2012 | 111 | 0.460 |
Why?
|
| Zinc Compounds | 1 | 2012 | 39 | 0.450 |
Why?
|
| Fluorides | 1 | 2012 | 133 | 0.430 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2020 | 4696 | 0.420 |
Why?
|
| Receptor, EphA1 | 1 | 2010 | 19 | 0.410 |
Why?
|
| Ubiquitination | 7 | 2020 | 999 | 0.410 |
Why?
|
| Proline | 1 | 2012 | 437 | 0.410 |
Why?
|
| Ubiquitin Thiolesterase | 4 | 2017 | 437 | 0.400 |
Why?
|
| Transcription Factors | 13 | 2022 | 11982 | 0.400 |
Why?
|
| Biocatalysis | 2 | 2012 | 182 | 0.400 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 583 | 0.390 |
Why?
|
| Calpain | 2 | 2009 | 158 | 0.380 |
Why?
|
| Ephrins | 1 | 2009 | 34 | 0.380 |
Why?
|
| Protein Folding | 4 | 2011 | 869 | 0.370 |
Why?
|
| Protein Multimerization | 5 | 2015 | 1012 | 0.370 |
Why?
|
| Histones | 3 | 2020 | 2585 | 0.360 |
Why?
|
| Protease Inhibitors | 3 | 2020 | 829 | 0.360 |
Why?
|
| Heterochromatin | 1 | 2011 | 302 | 0.350 |
Why?
|
| Models, Chemical | 3 | 2009 | 668 | 0.350 |
Why?
|
| Caspases | 1 | 2011 | 941 | 0.340 |
Why?
|
| Receptors, Purinergic P2X7 | 2 | 2018 | 92 | 0.340 |
Why?
|
| Drug Design | 7 | 2020 | 1109 | 0.340 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 6 | 2016 | 539 | 0.340 |
Why?
|
| Structure-Activity Relationship | 13 | 2021 | 3221 | 0.330 |
Why?
|
| Sequence Alignment | 8 | 2013 | 2298 | 0.330 |
Why?
|
| Ligands | 9 | 2022 | 3311 | 0.330 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3901 | 0.320 |
Why?
|
| Thiosulfate Sulfurtransferase | 1 | 2006 | 10 | 0.320 |
Why?
|
| Neoplasm Proteins | 4 | 2022 | 3884 | 0.310 |
Why?
|
| Substrate Specificity | 7 | 2017 | 1967 | 0.310 |
Why?
|
| Leukemia | 4 | 2017 | 1504 | 0.310 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 610 | 0.310 |
Why?
|
| Multigene Family | 1 | 2010 | 1173 | 0.300 |
Why?
|
| Adenosine Triphosphatases | 2 | 2015 | 896 | 0.300 |
Why?
|
| Catalysis | 4 | 2013 | 892 | 0.300 |
Why?
|
| Dimerization | 5 | 2012 | 916 | 0.290 |
Why?
|
| Protein Interaction Domains and Motifs | 4 | 2017 | 520 | 0.290 |
Why?
|
| DNA-Binding Proteins | 10 | 2017 | 9802 | 0.290 |
Why?
|
| Oligopeptides | 4 | 2020 | 1287 | 0.290 |
Why?
|
| Antineoplastic Agents | 10 | 2021 | 13763 | 0.280 |
Why?
|
| Aluminum Hydroxide | 2 | 2022 | 58 | 0.280 |
Why?
|
| Ubiquitins | 3 | 2020 | 419 | 0.280 |
Why?
|
| Cell Cycle Proteins | 4 | 2020 | 3513 | 0.280 |
Why?
|
| Nucleosomes | 3 | 2020 | 480 | 0.270 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2011 | 759 | 0.270 |
Why?
|
| Phosphoproteins | 5 | 2003 | 2574 | 0.270 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2020 | 754 | 0.260 |
Why?
|
| Molecular Structure | 9 | 2021 | 2020 | 0.260 |
Why?
|
| Multiprotein Complexes | 5 | 2013 | 1164 | 0.260 |
Why?
|
| Azepines | 2 | 2016 | 341 | 0.250 |
Why?
|
| DNA | 6 | 2015 | 7276 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 2984 | 0.240 |
Why?
|
| CpG Islands | 3 | 2015 | 1177 | 0.240 |
Why?
|
| Phenylalanine | 1 | 2004 | 382 | 0.240 |
Why?
|
| Thiophenes | 2 | 2017 | 601 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2015 | 3032 | 0.230 |
Why?
|
| HEK293 Cells | 11 | 2021 | 4334 | 0.230 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 326 | 0.230 |
Why?
|
| Phosphotyrosine | 4 | 2013 | 473 | 0.230 |
Why?
|
| DNA Methylation | 3 | 2015 | 4085 | 0.220 |
Why?
|
| Mannans | 1 | 2022 | 67 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 1406 | 0.220 |
Why?
|
| Protein Structure, Quaternary | 5 | 2012 | 462 | 0.220 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2020 | 5392 | 0.220 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2022 | 120 | 0.220 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 301 | 0.220 |
Why?
|
| Humans | 89 | 2022 | 709431 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 8733 | 0.210 |
Why?
|
| Proteins | 4 | 2022 | 6174 | 0.210 |
Why?
|
| Protein Kinase C | 1 | 2006 | 1295 | 0.210 |
Why?
|
| Mutation | 14 | 2022 | 29242 | 0.210 |
Why?
|
| CHO Cells | 3 | 2013 | 1443 | 0.210 |
Why?
|
| Molecular Conformation | 4 | 2011 | 588 | 0.210 |
Why?
|
| Iron-Binding Proteins | 1 | 2000 | 91 | 0.200 |
Why?
|
| Peptides | 4 | 2021 | 4503 | 0.200 |
Why?
|
| Thiazolidines | 1 | 2020 | 81 | 0.200 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2013 | 187 | 0.200 |
Why?
|
| Axonal Transport | 1 | 2021 | 190 | 0.200 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2020 | 324 | 0.200 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 32 | 0.200 |
Why?
|
| Cell Line, Tumor | 16 | 2020 | 17087 | 0.190 |
Why?
|
| STAT5 Transcription Factor | 2 | 2019 | 269 | 0.190 |
Why?
|
| Receptor, EphA3 | 2 | 2009 | 13 | 0.190 |
Why?
|
| Cell Proliferation | 11 | 2021 | 10858 | 0.190 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 2004 | 0.190 |
Why?
|
| Static Electricity | 2 | 2012 | 271 | 0.180 |
Why?
|
| Leukemia, T-Cell | 1 | 2019 | 114 | 0.180 |
Why?
|
| Sarcoma, Synovial | 1 | 2020 | 167 | 0.180 |
Why?
|
| Genes, Essential | 1 | 2020 | 182 | 0.180 |
Why?
|
| Animals | 34 | 2022 | 170647 | 0.180 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 312 | 0.180 |
Why?
|
| Serpins | 1 | 2020 | 272 | 0.180 |
Why?
|
| Candida albicans | 1 | 2022 | 370 | 0.180 |
Why?
|
| Recombinant Proteins | 7 | 2017 | 6946 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2020 | 3070 | 0.180 |
Why?
|
| Peptide Hydrolases | 2 | 2015 | 682 | 0.180 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 516 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 2 | 2014 | 670 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 732 | 0.170 |
Why?
|
| Apoproteins | 1 | 2017 | 50 | 0.170 |
Why?
|
| Disulfides | 1 | 2020 | 465 | 0.170 |
Why?
|
| Urea | 1 | 2020 | 443 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 2929 | 0.170 |
Why?
|
| Loss of Heterozygosity | 1 | 2020 | 691 | 0.160 |
Why?
|
| Antigens, Viral | 1 | 2022 | 1164 | 0.160 |
Why?
|
| Phosphorylation | 9 | 2021 | 8737 | 0.160 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 303 | 0.160 |
Why?
|
| Viral Vaccines | 1 | 2022 | 629 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 958 | 0.150 |
Why?
|
| beta Catenin | 1 | 2022 | 1063 | 0.150 |
Why?
|
| Arginine | 1 | 2020 | 952 | 0.150 |
Why?
|
| 2-Aminopurine | 1 | 2015 | 16 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 1573 | 0.150 |
Why?
|
| Signal Transduction | 8 | 2022 | 23985 | 0.150 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2017 | 154 | 0.150 |
Why?
|
| Phthalimides | 1 | 2015 | 16 | 0.150 |
Why?
|
| Amino Acids | 2 | 2012 | 1757 | 0.140 |
Why?
|
| Apoptosis | 7 | 2021 | 10133 | 0.140 |
Why?
|
| Evolution, Molecular | 3 | 2016 | 1970 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 1006 | 0.140 |
Why?
|
| Tretinoin | 1 | 2018 | 525 | 0.140 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 2283 | 0.140 |
Why?
|
| Cloning, Molecular | 4 | 2017 | 4547 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 619 | 0.140 |
Why?
|
| Mevalonic Acid | 1 | 1994 | 47 | 0.140 |
Why?
|
| Carboxy-Lyases | 1 | 1994 | 98 | 0.130 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2014 | 55 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2011 | 1807 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2002 | 1737 | 0.130 |
Why?
|
| Mice | 18 | 2022 | 80950 | 0.130 |
Why?
|
| Escherichia coli | 6 | 2017 | 4402 | 0.130 |
Why?
|
| Cyclopentanes | 1 | 2014 | 97 | 0.130 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2017 | 473 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2020 | 387 | 0.130 |
Why?
|
| Publications | 1 | 2016 | 200 | 0.120 |
Why?
|
| Carrier Proteins | 4 | 2018 | 5177 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 932 | 0.120 |
Why?
|
| Macromolecular Substances | 1 | 2016 | 1530 | 0.120 |
Why?
|
| Histidine | 2 | 2011 | 340 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 2067 | 0.120 |
Why?
|
| Pyrimidines | 2 | 2016 | 2959 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2018 | 3700 | 0.120 |
Why?
|
| Th2 Cells | 1 | 2018 | 1055 | 0.120 |
Why?
|
| Catechin | 1 | 2012 | 75 | 0.120 |
Why?
|
| Opioid Peptides | 1 | 2012 | 36 | 0.120 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2013 | 142 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2016 | 1117 | 0.120 |
Why?
|
| Proteomics | 3 | 2018 | 3226 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2022 | 1037 | 0.110 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 460 | 0.110 |
Why?
|
| Axons | 1 | 2021 | 1755 | 0.110 |
Why?
|
| Herpes Simplex | 1 | 2015 | 470 | 0.110 |
Why?
|
| Methyltransferases | 1 | 2015 | 351 | 0.110 |
Why?
|
| Ubiquitinated Proteins | 1 | 2011 | 41 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 981 | 0.110 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2012 | 173 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 1588 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2018 | 736 | 0.110 |
Why?
|
| Cricetulus | 1 | 2013 | 853 | 0.110 |
Why?
|
| Transformation, Bacterial | 1 | 2011 | 86 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2017 | 5508 | 0.110 |
Why?
|
| Quinolines | 1 | 2016 | 739 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2017 | 5136 | 0.110 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2012 | 135 | 0.110 |
Why?
|
| Entropy | 1 | 2012 | 208 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2019 | 3274 | 0.110 |
Why?
|
| Centrifugation | 1 | 2011 | 127 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 2987 | 0.110 |
Why?
|
| Cysteine | 2 | 2020 | 871 | 0.110 |
Why?
|
| Kinetics | 5 | 2013 | 6893 | 0.110 |
Why?
|
| Ephrin-A5 | 1 | 2010 | 16 | 0.100 |
Why?
|
| Ephrin-A1 | 1 | 2010 | 9 | 0.100 |
Why?
|
| src Homology Domains | 5 | 2019 | 374 | 0.100 |
Why?
|
| Cell Survival | 5 | 2021 | 6184 | 0.100 |
Why?
|
| DNA Replication | 2 | 2015 | 1461 | 0.100 |
Why?
|
| Crystallization | 2 | 2012 | 547 | 0.100 |
Why?
|
| Triazoles | 1 | 2016 | 915 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2020 | 3283 | 0.100 |
Why?
|
| Receptor, EphA2 | 1 | 2010 | 44 | 0.100 |
Why?
|
| RNA | 1 | 2021 | 2671 | 0.100 |
Why?
|
| Ligases | 1 | 2012 | 357 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2020 | 1946 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2011 | 175 | 0.100 |
Why?
|
| Cricetinae | 2 | 2012 | 2586 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2015 | 722 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2021 | 748 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2013 | 571 | 0.100 |
Why?
|
| Crystallography | 2 | 2007 | 112 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2021 | 11384 | 0.100 |
Why?
|
| Thalidomide | 1 | 2015 | 919 | 0.100 |
Why?
|
| Fluorescence Polarization | 1 | 2009 | 135 | 0.100 |
Why?
|
| Silicon Dioxide | 1 | 2011 | 257 | 0.090 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2013 | 290 | 0.090 |
Why?
|
| Receptors, Eph Family | 1 | 2009 | 48 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2013 | 665 | 0.090 |
Why?
|
| Surface Properties | 1 | 2012 | 1214 | 0.090 |
Why?
|
| Enzyme Activation | 6 | 2014 | 3904 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1801 | 0.090 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 1353 | 0.090 |
Why?
|
| Chemistry, Physical | 1 | 2008 | 164 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1406 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2018 | 1485 | 0.090 |
Why?
|
| Chemical Fractionation | 1 | 2008 | 71 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 525 | 0.090 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 293 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2011 | 927 | 0.080 |
Why?
|
| Glioma | 1 | 2022 | 3272 | 0.080 |
Why?
|
| Peptide Library | 1 | 2009 | 370 | 0.080 |
Why?
|
| 5-Methylcytosine | 1 | 2008 | 159 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1101 | 0.080 |
Why?
|
| Glucose | 1 | 2020 | 4239 | 0.080 |
Why?
|
| Spliceosomes | 1 | 2008 | 112 | 0.080 |
Why?
|
| Pyridines | 1 | 2020 | 2875 | 0.080 |
Why?
|
| Mammals | 2 | 2022 | 865 | 0.080 |
Why?
|
| Zinc | 1 | 2011 | 687 | 0.080 |
Why?
|
| Plasmids | 2 | 2011 | 2516 | 0.080 |
Why?
|
| Neoplasms | 3 | 2020 | 20421 | 0.080 |
Why?
|
| Phagocytosis | 2 | 2013 | 1596 | 0.080 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 881 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2014 | 4325 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 759 | 0.080 |
Why?
|
| Lipase | 1 | 2008 | 314 | 0.080 |
Why?
|
| Drug Discovery | 3 | 2020 | 1075 | 0.080 |
Why?
|
| Cell Line | 5 | 2015 | 16795 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2016 | 1954 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2008 | 231 | 0.070 |
Why?
|
| Tyrosine | 2 | 2008 | 1486 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2022 | 6768 | 0.070 |
Why?
|
| Multiple Myeloma | 2 | 2017 | 5050 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 1728 | 0.070 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 148 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 1990 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2017 | 3577 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 2032 | 0.070 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 2018 | 237 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2018 | 3073 | 0.070 |
Why?
|
| Epinephrine | 1 | 2008 | 807 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2020 | 4114 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2137 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2018 | 4409 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4282 | 0.070 |
Why?
|
| Solutions | 2 | 2016 | 417 | 0.070 |
Why?
|
| Amino Acid Motifs | 2 | 2021 | 977 | 0.070 |
Why?
|
| Phylogeny | 1 | 2012 | 2813 | 0.070 |
Why?
|
| Homeostasis | 2 | 2022 | 3328 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2008 | 553 | 0.060 |
Why?
|
| Inflammation | 2 | 2022 | 9948 | 0.060 |
Why?
|
| Protein Kinases | 2 | 2016 | 1682 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3339 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 7988 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1935 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 12468 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2020 | 8101 | 0.060 |
Why?
|
| Immune System | 1 | 2008 | 819 | 0.060 |
Why?
|
| Annelida | 1 | 2002 | 7 | 0.060 |
Why?
|
| Lamins | 1 | 2002 | 39 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2022 | 51 | 0.060 |
Why?
|
| Transcription Factor RelB | 1 | 2022 | 31 | 0.060 |
Why?
|
| Anura | 1 | 2002 | 87 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2002 | 119 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6564 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 1763 | 0.060 |
Why?
|
| Diptera | 1 | 2002 | 57 | 0.060 |
Why?
|
| Base Sequence | 2 | 2012 | 13429 | 0.060 |
Why?
|
| Water | 1 | 2008 | 1322 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2909 | 0.060 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2017 | 681 | 0.050 |
Why?
|
| Lamin Type A | 1 | 2002 | 175 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 338 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2016 | 1246 | 0.050 |
Why?
|
| beta-Glucans | 1 | 2022 | 124 | 0.050 |
Why?
|
| Lipodystrophy | 1 | 2002 | 146 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2891 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 477 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 2895 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 6659 | 0.050 |
Why?
|
| Pyruvate Carboxylase | 1 | 2020 | 20 | 0.050 |
Why?
|
| Friedreich Ataxia | 1 | 2000 | 64 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4605 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 3443 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2018 | 1300 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2018 | 15286 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2002 | 320 | 0.050 |
Why?
|
| Solubility | 1 | 2022 | 1175 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2020 | 1458 | 0.050 |
Why?
|
| DNA Primase | 1 | 2020 | 127 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 1999 | 580 | 0.050 |
Why?
|
| Muscular Dystrophies | 1 | 2002 | 393 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2022 | 1252 | 0.050 |
Why?
|
| Granzymes | 1 | 2020 | 283 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 444 | 0.050 |
Why?
|
| Models, Biological | 3 | 2013 | 9941 | 0.050 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1999 | 127 | 0.050 |
Why?
|
| Paranasal Sinuses | 1 | 2022 | 268 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 231 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 630 | 0.050 |
Why?
|
| Fishes | 1 | 2002 | 566 | 0.050 |
Why?
|
| Glycosylation | 2 | 2015 | 1129 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5227 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 695 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 619 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 23044 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2021 | 511 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 680 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2021 | 627 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2022 | 557 | 0.040 |
Why?
|
| Tryptophan | 1 | 2020 | 476 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 857 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2020 | 587 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2019 | 512 | 0.040 |
Why?
|
| Rats | 4 | 2013 | 25068 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 834 | 0.040 |
Why?
|
| Immunization | 1 | 2022 | 1289 | 0.040 |
Why?
|
| Lipids | 1 | 2008 | 3233 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2021 | 447 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 437 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 1129 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2022 | 13351 | 0.040 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2015 | 41 | 0.040 |
Why?
|
| Protein Interaction Mapping | 2 | 2011 | 642 | 0.040 |
Why?
|
| Shal Potassium Channels | 1 | 2015 | 24 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 489 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 1112 | 0.030 |
Why?
|
| Thrombosis | 1 | 2008 | 2798 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2758 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 1858 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1385 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2015 | 291 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 275 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 960 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 368 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 818 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1720 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 19798 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1412 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 2190 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 282 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2015 | 211 | 0.030 |
Why?
|
| Rod Cell Outer Segment | 1 | 2013 | 62 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 567 | 0.030 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2013 | 107 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2014 | 185 | 0.030 |
Why?
|
| Calmodulin | 1 | 2013 | 220 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2013 | 97 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2857 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 539 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1378 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2013 | 78 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6059 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2786 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1665 | 0.030 |
Why?
|
| Calorimetry | 1 | 2012 | 129 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 5995 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 647 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2858 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 1996 | 861 | 0.030 |
Why?
|
| Iron | 1 | 2000 | 1720 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2012 | 183 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 1123 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 1358 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 913 | 0.030 |
Why?
|
| RING Finger Domains | 1 | 2010 | 9 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2011 | 112 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 564 | 0.030 |
Why?
|
| Triticum | 1 | 2011 | 95 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2011 | 251 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2020 | 2109 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2013 | 2518 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2012 | 802 | 0.030 |
Why?
|
| Choroid | 1 | 2013 | 316 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 1917 | 0.030 |
Why?
|
| Cyclin D3 | 1 | 2010 | 54 | 0.020 |
Why?
|
| Female | 8 | 2021 | 377269 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 2847 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2018 | 1329 | 0.020 |
Why?
|
| Pyrroles | 1 | 2017 | 1206 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3431 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2012 | 598 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2010 | 116 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2022 | 2929 | 0.020 |
Why?
|
| Trypsin | 1 | 2010 | 542 | 0.020 |
Why?
|
| Adenosine | 1 | 2015 | 840 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 3025 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2020 | 3556 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 1961 | 0.020 |
Why?
|
| Cryoelectron Microscopy | 1 | 2012 | 527 | 0.020 |
Why?
|
| Paraoxon | 1 | 2008 | 2 | 0.020 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1581 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8581 | 0.020 |
Why?
|
| Immunophilins | 1 | 2008 | 22 | 0.020 |
Why?
|
| Chickens | 1 | 2011 | 881 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 2963 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 282 | 0.020 |
Why?
|
| Genome | 1 | 2017 | 1729 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10475 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 7123 | 0.020 |
Why?
|
| Thiolester Hydrolases | 1 | 2009 | 103 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1588 | 0.020 |
Why?
|
| Point Mutation | 1 | 2014 | 1669 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3660 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 4925 | 0.020 |
Why?
|
| Yeasts | 1 | 2009 | 294 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1688 | 0.020 |
Why?
|
| Insulin | 1 | 2003 | 6638 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 938 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 1030 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 966 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2018 | 4312 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2018 | 6185 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1569 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3651 | 0.020 |
Why?
|
| Niacinamide | 1 | 2009 | 443 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2008 | 237 | 0.020 |
Why?
|
| Macrophages | 1 | 2022 | 5774 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 6077 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2455 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9966 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4506 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 5242 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2008 | 536 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 2052 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 5231 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2282 | 0.020 |
Why?
|